Simone Krebs

Associate Professor

The University of Texas MD Anderson Cancer Center

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Simone Krebs is an Associate Professor at The University of Texas MD Anderson Cancer Center, located in the United States. Her research primarily focuses on radiotheranostics, immuno-PET, and targeted cancer therapies, as evidenced by her recent publications on topics such as metastatic prostate cancer treatment and the engineering of CAR-T cells for enhanced imaging and therapy applications. She actively contributes to the advancement of cancer treatment methodologies through her work and participation in workshops and conferences.

Articles (10)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Collaborators (2)

Mads Hald Andersen

Professor, dr.techn., Director

DENMARK

View details

Jie Deng

University of California, Los Angeles

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Simone Krebs

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Harnessing the tumor microenvironment: targeted cancer therapies through modulation of epithelial-mesenchymal transition.

Today’s Research, Tomorrow’s Practice – White Paper from the Translation of New Therapy (TNT) Radiotheranostics Kick-off Pre-meeting of the Annual World Molecular Imaging Conference 2024

Lesion Absorbed Dose-Response Relationship in Patients with Metastatic Castration-Resistant Prostate Cancer Undergoing [177Lu]Lu-PSMA-617 Radiopharmaceutical Therapy.

Symptomatic Prostate-Specific Membrane Antigen PET-Positive Radionecrosis After Multimodality Brain Metastasis-Directed Treatment Including [177Lu]Lu-PSMA-617.

IL13Rα2-Targeting Antibodies for Immuno-PET in Solid Malignancies.

Machine-learning based quantification of lung shunt fraction from 99mTc-MAA SPECT/CT for selective internal radiation therapy of liver tumors using TriDFusion (3DF).

Proceedings of the National Cancer Institute Workshop on combining immunotherapy with radiotherapy: challenges and opportunities for clinical translation.

Theranostic GPA33-Pretargeted Radioimmunotherapy of Human Colorectal Carcinoma with a Bivalent 177Lu-Labeled Radiohapten.

Tumors Affect the Metabolic Connectivity of the Human Brain Measured by 18F-FDG PET

Engineering CAR-T cells for radiohapten capture in imaging and radioimmunotherapy applications.

Collaborators (2)

Mads Hald Andersen

Jie Deng

Make your next move.